HGF and neoplasm: The MET receptor belongs to the family of growth factor receptors with intrinsic tyrosine kinase activity and, together with its ligand, Hepatocyte Growth Factor (HGF), is involved in proliferation, inhibition of apoptosis, motility and dissemination of cancer cells during tumor development and progression [3, 4].